levofloxacin / Generic mfg. |
ChiCTR2000029096: A clinical study for the permeability of levofloxacin in the bronchi and lung tissues |
|
|
| Completed | 4 | 72 | | Oral single dose of levofloxacin tablet 500mg ;Oral single dose of levofloxacin tablet 500mg | Huashan Hospital Affiliated to Fudan University; Huashan Hospital Affiliated to Fudan University, Daiichi Sankyo Co., Ltd. | Lower respiratory tract infection | | | | |
ChiCTR-TRC-12002693: Comparative Study of Human Aqueous Humor Levels of Gatifloxacin 0.3% Eye Gel, Gatifloxacin 0.3% and Levofloxacin 0.5% Ophthalmic Solution after Topical Dosing |
|
|
| Completed | 4 | 150 | | One drop of gatifloxacin 0.3% eye gel was administration ;One drop of gatifloxacin 0.3% ophthalmic solution ;One drop of levofloxacin 0.5% ophthalmic solution | Zhejiang University; Zhejiang University, Zhejiang Key Innovation Team Project of China (2009R50039); Zhejiang Key Laboratory Fund of China (2011E10006) | endoophthalmitis after cataract surgery | | | | |
2011-002177-34: Population pharmacokinetics of levofloxacin in intensive care patients with severe community-acquired pneumonia Pharmacocinétique de population de la lévofloxacine chez des patients de réanimation présentant une pneumopathie communautaire |
|
|
| Not yet recruiting | 4 | 65 | Europe | Tavanic, NA, Solution for injection/infusion, TAVANIC 5 mg/ml, solution pour perfusion | CHU de Toulouse, Appel d'offre local 2010 | community-acquired pneumonia Pneumopathie communautaire, community-acquired pneumonia, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
2006-001527-19: ENSAYO CLÍNICO ALEATORIZADO FASE IV PARA EVALUAR LA EFICACIA COMPARATIVA DEL TRATAMIENTO CON AMOXICILINA-CLAVULÁNICO O LEVOFLOXACINO EN PACIENTES CON NEUMONÍA ADQUIRIDA EN LA COMUNIDAD (NAC) |
|
|
| Ongoing | 4 | 120 | Europe | AUGMENTINE INTRAVENOSO, TAVANIC, AUGMENTINE PLUS, 9857622, AUGMENTINE INTRAVENOSO, TAVANIC, AUGMENTINE PLUS, AUGMENTINE INTRAVENOSO, TAVANIC, AUGMENTINE PLUS | Hospital Universitario de Canarias | Neumonía adquirida en la comunidad de gravedad leve-moderada (PSI I-III) | | | | |
2006-006842-33: Estudio Piloto Comparativo de Eficacia, Tolerancia y Seguridad de Moxifloxacino VO frente a Levofloxacino en Terapia Secuencial en Adultos Inmunocompetentes con Neumonía Adquirida en la Comunidad. |
|
|
| Ongoing | 4 | 80 | Europe | Actira, Tavanic, Actira, Tavanic | Fundación para Investigación y Desarrollo en el Área Cardiovascular del Hospital Clínico San Carlos | Neumonía adquirida en la comunidad | | | | |
2007-001701-19: pharmacokinetic study by microdialysis of the distribution of ertapeneme and levofloxacine in infected foot ulcers of diabetics patients. |
|
|
| Ongoing | 4 | 8 | Europe | TAVANIC, INVANZ, TAVANIC, INVANZ, TAVANIC, INVANZ | CHU DE POITIERS | infected foot ulcers in diabetic patient | | | | |
2008-001892-31: Ensayo clínico unicéntrico, simple ciego y aleatorizado de comparación de la eficacia erradicadora de primera línea frente al Helicobacter pylori entre la triple terapia convencional oral con claritromicina, amoxicilina y omeprazol (CAO) durante 10 días frente a triple terapia alternativa oral con levofloxacino, amoxicilina y omeprazol (LAO) durante 10 díasSingle-blind, randomised, unicentric, prospective Clinical Trial comparing the Helicobacter pylori eradication effectiveness of two oral ten-day regimens: conventional triple therapy with clarytromicin, amoxicillin and omeprazole (CAO) and alternative therapy with levofloxacin, amoxicillin and omeprazole (LAO). |
|
|
| Ongoing | 4 | 250 | Europe | LEVOFLOXACIN, AMOXICILLIN, CLARITHROMYCIN, OMEPRAZOLE, LAO, CAO, | Hospital Comarcal de Laredo. Sección de Digestivo | Situaciones clínicas donde esté recomendada la erradicación del Helicobacter Pylori:(ej. úlcera gastroduodenal, en familiares de primer grado de pacientes con cáncer gástrico o pacientes con dispepsia funcional resistente al tratamiento). Clinical settings where eradication of Helicobacter Pylori is indicated: (i.e. all cases of peptic gastroduodenal ulcers, 1st grade familiar of patients with diagnosed gastric cancer or patients with functional dyspepsia resistant to therapy). | | | | |
2009-014054-14: Comparison of the Safety of Intracameral Levofloxacin to intracameral Cefuroxime for the prevention of endophthalmitis in cataract surgery (SILC) |
|
|
| Ongoing | 4 | 30 | Europe | Oftaquix Unit Dose 5mg/mL eye drops, Zinacef, Oftaquix Unit Dose 5mg/mL eye drops, Zinacef | Guys\' and St Thomas\' NHS Foundation Trust, Joint Clinical Trials Office | Cataracts and endophthalmitis | | | | |
2013-001976-39: Day/night rhythms in the uptake and elimination of the antibiotic Levofloxacin Een onderzoek naar de dag/nacht ritmes in de opname en afbraak van het antibioticum Levofloxacine. |
|
|
| Ongoing | 4 | 12 | Europe | Levofloxacine 500 mg, filmomhulde tabletten, Levofloxacine 500 mg, filmomhulde tabletten | Centre for Human Drug Research, Stichting Technologie en Wetenschap | The circadian variation in the relative contribution of intestinal uptake and renal elimination of levofloxacin De dag/nacht ritmes in de opname en afbraak van het antibioticum Levofloxacine. | | | | |
2015-003633-10: Optimizing the antibiotic treatment of uncomplicated acute appendicitis |
|
|
| Ongoing | 4 | 552 | Europe | Tablet, Powder for solution for injection/infusion, Moxifloxacin, Levofloxacin, Metronidazole, Ertapenem | Turku University Hospital | Uncomplicated acute appendicitis, Appendicitis, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02] | | | | |
ChiCTR-IPR-15006189: A randomized control trial of levofloxacin, terazosin and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome |
|
|
| Recruiting | 4 | 114 | | levofloxacin ;terazosin ;combination therapy | Binzhou Medical University Hospital; None, self-funded | Type III chronic prostatitis/chronic pelvic pain syndrome | | | | |
2015-003634-26: Antibiotic therapy vs. placebo in the treatment of appendicitis |
|
|
| Ongoing | 4 | 142 | Europe | Powder for solution for injection/infusion, Capsule, soft, Invanz (Ertapenem), Metronidazole, Levofloxacin | Turku University Hospital | Acute uncomplicated appendicitis, Appendicitis, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02] | | | | |
2016-003655-29: Etiology of appendicitis and effects of antimicrobial treatment |
|
|
| Ongoing | 4 | 200 | Europe | Powder for solution for injection/infusion, Capsule, soft, Tablet, Invanz (Ertapenem), Metronidazole, Levofloxacin, Moxifloxacin | Turku University Hospital | Acute appendicitis, Appendicitis, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02] | | | | |
ChiCTR-IPR-17012879: Bismuth plus triple therapy adjusted according to medication history in the first-line eradication of Helicobacter pylori infection: a randomized trial |
|
|
| Not yet recruiting | 4 | 800 | | Bismuth plus triple therapy (clarithromycin) ;Bismuth plus triple therapy (levofloxacin) ;Bismuth plus triple therapy (metronidazole) ;Bismuth plus triple therapy adjusted according to medication history | Department of Gastroenterology, Peking University Third Hospital; Department of Gastroenterology, Peking University Third Hospital, Projects from the National Science Technology Pillar Program in the Twelfth Five-Year Plan Period, China | Helicobacter pylori infection | | | | |
2019-000955-16: Characterization of lung concentrations of the antibiotics piperacillin/tazobactam and levofloxacin |
|
|
| Ongoing | 4 | 18 | Europe | Powder for concentrate for solution for infusion, , Piperacillin/Tazobactam "Kabi" - Fresenius Kabi Austria, Levofloxacin "Kabi" | Medical University of Vienna, Medical University Vienna | Pneumonia, Pneumonia, Lung infection, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
| Not yet recruiting | 4 | 310 | Europe | AMOXICILLIN, AMOXICILLIN-CLAVULANATE, AMPICILLIN, ERYTHROMYCIN, CLARITHROMYCIN, PRISTINAMYCIN, CIPROFLOXACIN, LEVOFLOXACIN, MOXIFLOXACIN, OFLOXACIN, AZITHROMYCIN, Buccal tablet | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, DGOS | Community acquired pneumonia, Community acquired pneumonia, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
ChiCTR-IPR-17011239: efficacy of prophylactic Levofloxacin for prevention of gut infection among de-novo AML patients: a randomised study |
|
|
| Recruiting | 4 | 120 | | prophylactic Levofloxacin ;no prophylactic antibiotics | Rui Jin hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai Institute of Hematology; Rui Jin hospital affiliated to Shanghai Jiaotong University School of Medicine, self-financing | Acute myeloid leukemia | | | | |
NCT04432233: Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease |
|
|
| Recruiting | 4 | 60 | RoW | Esomeprazole, Metronidazole, Levofloxacin | Shanghai Jiao Tong University School of Medicine | Helicobacter Pylori Infection, Intravenous Drug Usage | 04/21 | 06/21 | | |
2021-001468-13: Study of the absorption of oral antibiotics known for their good ability to cross the barrier of the stomach and intestine to reach the blood in patients with short bowel syndrome Etude de l'absorption d'antibiotiques oraux connus pour leur bonne capacité à franchir la barrière de l'estomac et de l'intestin pour atteindre le sang chez des patients atteints du syndrome du grêle court |
|
|
| Not yet recruiting | 4 | 10 | Europe | Powder for oral suspension, Film-coated tablet, Oral suspension, AMOXICILLINE, Amoxicilline/acide clavulanique, LEVOFLOXACINE, OFLOXACINE, BACTRIM | Centre Hospitalier Régional Universitaire de Nancy, Centre Hospitalier Régional Universitaire de Nancy | Patient with short bowel syndrome treated with antibiotics for urinary parenchymal infection Patient présentant un syndrome de grêle court et traités par antibiotiques pour une infection urinaire parenchymateuse, Patient with short bowel syndrome treated with antibiotics for urinary parenchymal infection Patient présentant un syndrome de grêle court et traités par antibiotiques pour une infection urinaire parenchymateuse, Diseases [C] - Digestive System Diseases [C06] | | | | |
2016-001780-37: Prospective randomized controlled study of two antibiotic treatment times (3 versus 6 weeks) of diabetic foot osteomyelitis Étude prospective randomisée contrôlée de deux durées de traitement antibiotique (3 versus 6 semaines) de l’ostéite du pied diabétique |
|
|
| Not yet recruiting | 4 | 60 | Europe | Bactrim forte, Ciprofloxacine, Clindamycine, Doxycycline, Ceftazidime, Fucidine, Minocycline, Ofloxacine, Rifampicine, Teicoplanine, Levofloxacine, Tablet, Solution for infusion, Bactrim forte, Ciprofloxacine, Clindamycine, Doxyxycline, Ceftazidime, Fucidine, Minocycline, Ofloxacine, Rifampicine, Teicoplanine, Levofloxacine | Centre Hospitalier de Tourcoing, Centre Hospitalier de Tourcoing | Patients de plus de 18 ans et de moins de 80 ans.Présentant une ostéite du pied diabétique., Patients de plus de 18 ans et de moins de 80 ans.Présentant une ostéite du pied diabétique., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02] | | | | |
NCT06221345: Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease |
|
|
| Completed | 4 | 70 | RoW | Systane HYDRATION® Preservative-Free Lubricant Eye Drops, Optive Fusion® Lubricant Eye Drops (Unit Dose) | Chang Gung Memorial Hospital | Dry Eye Disease, Cataract | 07/23 | 07/23 | | |
2020-001024-34: Oral antimicrobial treatment vs. outpatient parenteral for infectiveendocarditis. Tratamiento antimicrobiano oral vs. parenteral ambulatorio para la endocarditis infecciosa |
|
|
| Not yet recruiting | 4 | 360 | Europe | amoxicillin, cefaclor, ciprofloxacin, clindamycin, Dicloxacillin, Fusidic acid, Fusidic Acid, Levofloxacin, levofloxacin, Linezolid, Moxifloxacin, Rifampicin, Sulfamethoxazole/trimethoprim, sulfamethoxazole /trimethoprin, Tedizolid, cefaclor, Dicloxacillin, Dicloxaxillin ev, Rifampicina, septrin, 49708-146-01, 856866-72-3, Tablet, Injection, Solution for injection, Solution for infusion, Capsule, Concentrate for solution for injection/infusion, , Film-coated tablet, Coated tablet, Solution for solution for infusion, Concentrate for solution for infusion, Concentrate and solvent for solution for infusion, Concentrate and solvent for concentrate for solution for infusion, Amoxicillin, ciprofloxacin | Fundació Clínic per a la Recerca Biomèdica, Instituto de Salud Carlos III | infective endocarditis endocarditis infecciosa, infective endocarditis endocarditis infecciosa, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2021-003847-10: A study comparing a 7-day versus a 14-day course of antibiotics against an infection affecting the blood caused by a bacteria called Pseudomonas aeruginosa. Estudio en el que se compara un tratamiento con antibióticos de 7 dÃas frente a uno de 14 dÃas de duración contra una infección que afecta a la sangre producida por una bacteria llamada Pseudomonas aeruginosa. |
|
|
| Ongoing | 4 | 304 | Europe | Tablet, Solution for infusion, Powder for infusion, Powder for solution for infusion, Ciprofloxacin, Levofloxacin, Piperacillin/Tazobactam, Ceftazidime, Cefepime, Ceftazidime/Avibactam, Ceftolozane/Tazobactam, Imipenem, Meropenem, Meropenem-Vaborbactam, Colistin, Amikacin, Tobramycin, Aztreonam | Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI), ICI21/00075 (ISCIII) | Adult patients with bloodstream infections produced by Pseudomonas aeruginosa. Pacientes adultos con bacteriemia producida por Pseudomonas aeruginosa., Adult patients with infections that produce the passing of Pseudomonas aeruginosa bacteria to the blood. Pacientes adultos con infecciones que producen el paso de bacterias de Pseudomonas aeruginosa a la sangre., Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
ACTRN12622000149763: Rectal and urethral flora in patients undergoing transrectal ultrasound guided prostate biopsy: clinical implications. |
|
|
| Completed | 4 | 200 | | | Sotirios Gatsos | Urinary tract infections, Infectious complications of transrectal ultrasound guided prostate biopsy, Prostate cancer, Prostatitis | | | | |
| Recruiting | 4 | 500 | RoW | Naïve patients - ACO therapy, Naïve patients - LNDL therapy, Naïve patients - MNDL therapy, Treatment-experienced patients- LNDL therapy, Treatment-experienced patients- MNDL therapy | National Liver Institute, Egypt, Future pharmaceutical industries | Helicobacter Pylori | 02/22 | 03/22 | | |
ChiCTR2100042499: Study on standardized use of topical antibiotics eye drops before cataract surgery |
|
|
| Recruiting | 4 | 723 | | One group receive topical 0.5% levofloxacin eyedrops six times a day for 1 day ;One group receive topical 0.5% levofloxacin eyedrops four times a day for 2 days ;One group receive topical 0.5% levofloxacin eyedrops four times a day for 3 days | Beijing Chaoyang Hospital, Capital Medical University; Beijing Chaoyang Hospital, Capital Medical University, Beijing Hospitals Authority Youth Programme (No. QML20190303) | Endophthalmitis after cataract surgery | | | | |
NCT05129176: Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin |
|
|
| Recruiting | 4 | 106 | RoW | Levofloxacin, Metronidazole | Shandong University | Helicobacter Pylori Infection | 07/22 | 11/22 | | |
NCT04204382: Effects of CKI for Oral Mucositis Caused by Radiotherapy for Head and Neck Cancer |
|
|
| Recruiting | 4 | 144 | RoW | Levofloxacin Injection, Zuoyangfushaxing Zhusheye, Compound Kushen Injection(CKI), Yanshu injection | Shanxi Zhendong Pharmacy Co., Ltd | Radiation-induced Oral Mucositis | 09/22 | 12/22 | | |
NCT04122287: Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin |
|
|
| Recruiting | 4 | 250 | RoW | Levofloxacin, tinidazole | Shandong University | Helicobacter Pylori Infection | 10/22 | 12/22 | | |
| Terminated | 4 | 205 | RoW | Individualized TB treatment with multiple drugs, Standardized TB treatment with multiple drugs | Centre for the AIDS Programme of Research in South Africa | Tuberculosis, Multidrug-Resistant | 12/22 | 12/22 | | |
NCT05023577: Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients |
|
|
| Recruiting | 4 | 504 | RoW | Rabeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin | Shanghai Zhongshan Hospital | Helicobacter Pylori Infection | 12/22 | 12/22 | | |
NCT05250050: Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment |
|
|
| Recruiting | 4 | 388 | RoW | Esomeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin, Amoxicillin, Tetracycline | Shanghai Zhongshan Hospital | Helicobacter Pylori Infection | 12/22 | 03/23 | | |
ChiCTR2100045158: Clinical effect study of Babaodan capsule combined with antibiotics on acute pyelonephritis |
|
|
| Recruiting | 4 | 90 | | add BaBaoDan ;Antibiotic (levofloxacin) | Shantou Central hospital; Shantou Central Hospital, self-raised | acute pyelonephritis | | | | |
NCT04332848: Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection |
|
|
| Recruiting | 4 | 360 | RoW | ET, SGT | National Taiwan University Hospital | Helicobacter Pylori Infection | 03/23 | 03/23 | | |
RiCOTTA, NCT06172010: Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection |
|
|
| Recruiting | 4 | 316 | Europe | Clindamycin, Rifampicin and levofloxacin | Leiden University Medical Center, University Medical Center Groningen, Onze Lieve Vrouwe Gasthuis, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Medical Centre Leeuwarden, Isala, Martini Hospital Groningen, Radboud University Medical Center, Sint Maartenskliniek, Elisabeth-TweeSteden Ziekenhuis, Erasmus Medical Center, Alrijne Hospital, Spaarne Gasthuis, Reinier Haga Orthopedisch Centrum, Tergooi Hospital, Rijnstate Hospital | Prosthetic-joint Infection, Infection Hip, Infection; Knee, Joint | 03/27 | 03/28 | | |
NCT05079620: Early Antibiotics After Aspiration in ICU Patients |
|
|
| Terminated | 4 | 5 | US | Ceftriaxone, Amoxicillin clavulanic acid, Augmentin, Cefepime, Vancomycin, Levofloxacin | UConn Health | Aspiration, Aspiration Pneumonia | 04/24 | 04/24 | | |
| Completed | 4 | 354 | RoW | PZA sensitivity guided ultra-short all Oral Regimen, Standardized Shorter Regimen | Huashan Hospital | Multidrug Resistant Tuberculosis | 08/24 | 08/24 | | |
NCT06050824: A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection |
|
|
| Completed | 4 | 200 | RoW | Comparing Load and Concomitant therapy, Clarithromycin - pantoprazole - Metronidazole - Amoxycyllin | Helwan University | H. Pylori Infection | 07/23 | 07/23 | | |
NCT05313750: Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in Adults |
|
|
| Active, not recruiting | 4 | 256 | RoW | anti-infective therapy sitafloxacin, anti-infective therapy levofloxacin | Shanghai Pulmonary Hospital, Shanghai, China | Acute Exacerbation of Bronchiectasis | 12/23 | 06/24 | | |
| Recruiting | 4 | 80 | RoW | Doxycycline, Tinadizole, Esomeprazole, levofloxacine, Levofloxacin 500mg, Amoxicilline, Esomeprazol | Damascus Hospital | Helicobacter Pylori Infection | 12/23 | 05/24 | | |
ChiCTR2200066312: A multicenter, randomized, double-blind, double-simulated, positive-controlled, non-inferior clinical trial of non-antimicrobial therapy (Yinhua MIYANLING Pian) and antimicrobial therapy (levofloxacin) for the treatment of uncomplicated urinary tract infections |
|
|
| Recruiting | 4 | 542 | | Yinhua Miyanling tablet (4 tablets, 4 times a day for 7 days) + levofloxacin tablet simulator (500 mg, 1 time a day for 3 days) ;Yinhua Miyanling tablet simulator (4 tablets, 4 times a day for 7 days) + levofloxacin tablet (500 mg, 1 time a day for 3 days) ;Yinhua Miyanling tablet (4 tablets 4 times daily for 28 Days) + levofloxacin tablet simulator (500 mg, 1 time a day for 3 days) ;Yinhua Miyanling tablet simulator (4 tablets, 4 times daily for 28 Days) + levofloxacin tablet (500 mg, 1 time a day for 3 days) | Beijing Tongren Hospital, Capital Medical University; WU JIEPING MEDICAL FOUNDATION, All the funds for this experiment are provided by the initiating unit, and the contract is signed to explain the specific funding provision | Uncomplicated urinary tract infections、Acute onset of recurrent urinary tract infections | | | | |
NCT06088316: Efficacy of Amoxicillin-Esomeprazole HDDT Compared to Levofloxacin Triple Therapy for H. Pylori Eradication: A RCT |
|
|
| Recruiting | 4 | 70 | RoW | group A : Amoxicillin Esomeprazole HDDT, group-B : Levofloxacin triple therapy | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Helicobacter Pylori Infection, Helicobacter Pylori Eradication | 02/24 | 02/24 | | |
| Recruiting | 4 | 200 | US | Ceftriaxone, Rocephin, Levofloxacin, Levaquin | University of Southern California | Cholangitis | 02/24 | 02/24 | | |
| Terminated | 4 | 90 | US | Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, metronidazole, moxifloxacin, rifampin, trimethoprim-sulfamethoxazole, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem, meropenem, oritavancin, oxacillin, penicillin, piperacillin-tazobactam, tigecycline, vancomycin | West Virginia University | Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection, Pulmonary Infection, Gastrointestinal Infection, Genitourinary Infection | 02/25 | 02/25 | | |
NCT06351891: Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin |
|
|
| Not yet recruiting | 4 | 248 | RoW | 14-day bismuth quadruple regimen containing cefuroxime and tetracycline, 14-day bismuth quadruple regimen containing cefuroxime and levofloxacin | Qilu Hospital of Shandong University | Helicobacter Pylori Infection | 12/24 | 12/24 | | |
| Recruiting | 4 | 360 | Europe | Cefaclor, Ciprofloxacin Tablets, Ciprofloxacin Injection, Clindamycin Oral Capsule, Clindamycin Injection, Dicloxacillin Oral Capsule, Dicloxacillin, Fusidic Acid Only Product in Oral Dose Form, Fusidic Acid Only Product in Parenteral Dose Form, Levofloxacin Oral Tablet, Levofloxacin Injection, Linezolid Oral Tablet, Linezolid Injectable Product, Moxifloxacin tablet, Moxifloxacin Injectable Product, Rifampicin Only Product in Oral Dose Form, Rifampicin Only Product in Parenteral Dose Form, Sulfamethoxazole / Trimethoprim Oral Tablet [Bactrim], Sulfamethoxazole / Trimethoprim Injectable Product, Tedizolid Oral Tablet, Tedizolid Injection, Amoxicillin Capsules, Amoxicillin, Cefaclor Capsules | Fundacion Clinic per a la Recerca Biomédica | Endocarditis Infective | 10/26 | 12/27 | | |
NCT05575427: Efficacy of Combination Therapy With Minocycline for Treatment of Stenotrophomonas Maltophilia Infections |
|
|
| Recruiting | 4 | 112 | RoW | Minocycline, Mino, Levofloxacin or Cotrimoxazole, Cravit or Bactrim, Placebo | Mahidol University | Hospital Infections | 07/24 | 11/24 | | |
NCT06494072: Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP |
|
|
| Recruiting | 4 | 236 | US | Ampicillin for Injection, Ceftriaxone for Injection, Rocephin, Amoxicillin, Ampicillin / Sulbactam Injection, Unasyn, Amoxicillin-clavulanate, Augmentin, Clindamycin, Cleocin, Cefprozil, Cefzil, Levofloxacin, Levaquin | Medical College of Wisconsin | Community Acquired Pneumonia in Children | 05/27 | 05/27 | | |
NCT04502095: Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy |
|
|
| Active, not recruiting | 4 | 89 | US | Clindamycin, Cleocin, Diary, Ertapenem, Levofloxacin, (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic Acid Hydrate (2:1), Levaquin, Levofloxacin Hydrate, Quixin, Nitrofurantoin, Macrobid, Macrodantin, Trimethoprim-Sulfamethoxazole, Bactrim, Bactrim DS, Bactrimel, Centran, Centrin, Co-Trimoxazole, Cotrim, Cotrimoxazole, Eslectin, Insozalin, Septra, SMZ-TMP, Sulfamethoprim, Sulfatrim, Sulmeprim, TMP-SMX, Trimedin, Trimezole, Uroplus | Roswell Park Cancer Institute | Bladder Carcinoma, Refractory Bladder Carcinoma, Urinary Tract Infection | 03/24 | 03/25 | | |
OPTIMAL, NCT05156437: Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis |
|
|
| Enrolling by invitation | 4 | 20 | US | Amoxycillin, Cefalexin, Dicloxacillin, Linezolid, Levofloxacin, Rifampicin, Ampicillin, Oxacillin, Vancomycin, Daptomycin, Ceftriaxone, Cefepime, Ceftaroline | Vinay Badhwar | Endocarditis | 10/24 | 10/24 | | |
ChiCTR2200066299: Comparison of the effect of two antibiotic treatment regimens on the cure rate of chronic endometritis: a prospective randomized controlled trial |
|
|
| Recruiting | 4 | 182 | | oral doxycycline 200 mg daily for 14 days ;Oral levofloxacin 500 mg and tinidazole 1000 mg daily for 14 days | Affiliated Hospital of North Sichuan Medical College; Affiliated Hospital of North Sichuan Medical College, None | Chronic endometritis | | | | |
| Enrolling by invitation | 4 | 200 | RoW | Levofloxacin, Cefmetazole (drug) | National Taiwan University Hospital | Retrograde Intrarenal Surgery, Renal Stones | 06/26 | 06/26 | | |
ChiCTR2400084341: Observation of the effectiveness of 0.05% cyclosporine eye drops (II) in the treatment of dry eye patients after refractive surgery |
|
|
| Not yet recruiting | 4 | 80 | | Drug intervention was used in this study. Specific intervention measures: 80 patients with ametropia who intended to undergo Smile full femtosecond surgery without obvious dry eyes before surgery were included, and 40 patients in the experimental group and 40 patients in the control group were included in the right eye for observation. Random grouping. All patients were treated with levofloxacin combined with loteprednol eye drops four times a day within one week after surgery. Experimental group: 0.1% sodium hyaluronate combined with 0.05% cyclosporine eye drops (II) twice a day; Control group: Only 0.1% sodium hyaluronate was treated 4 times a day.; Control group, 40 cases, were included in the right eye observation. All patients were treated with levofloxacin combined with loteprednol eye drops four times a day within one week after surgery. Control group: Only 0.1% sodium hyaluronate was treated 4 times a day. | Peking Union Medical College Hospital; PEKING UNION MEDICAL COLLEGE HOSPITAL, Beijing Bethune Foundation | DRY EYE | | | | |
ChiCTR2400084823: Clinical study of Longqing tablets in the treatment of acute uncomplicated lower urinary tract infection |
|
|
| Recruiting | 4 | 180 | | Levofloxacin tablets, twice a day, one tablet at a time, with a treatment period of 7 days; Longqing tablets, twice a day, six tablet at a time, with a treatment period of 7 days; Levofloxacin + Longqing tablets, administered with an interval of 30min for 7 days | Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Self-funded | acute uncomplicated lower urinary tract infection | | | | |
FRANCiS-NF, NCT05393505: Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection |
|
|
| Recruiting | 4 | 344 | RoW | Meropenem Injection, Levofloxacin, Amoxicillin Clavulanate, Augmentin, Antibiotic, IMPACT guideline | The University of Hong Kong, Queen Mary Hospital, Hong Kong | Neutropenic Fever | 03/25 | 06/25 | | |
PROSPECT, NCT05306223: A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China |
|
|
| Recruiting | 4 | 212 | RoW | Bedaquiline, SIRTURO, Levofloxacin, Linezolid, Cycloserine, Clofazimine, Pyrazinamide, Protionamide | Beijing Chest Hospital | Tuberculosis, Multidrug-Resistant | 08/25 | 08/25 | | |
NCT05332444: Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection |
|
|
| Recruiting | 4 | 450 | RoW | susceptibility-guided tailored therapy (Group A), Proton pump inhibitor: Rabeprazole, Pariet®, Antibiotics: Amoxicillin, Amoxicillin®; Clarithromycin, Klaricid®; Levofloxacin, Cravit®; Metronidazole, Metrozole®; Tetracyclline, tetracycline®, Colloidal Bismuth: Tripotassium dicitrate bismuthate, KCB®, guidelines-recommended empiric therapy (Group B), Antibiotics: Metronidazole, Metrozole®; Tetracyclline, tetracycline® | National Taiwan University Hospital | Helicobacter Pylori Infection | 09/25 | 12/25 | | |
NCT06200779: Tailored Vs. Empirical Helicobacter Pylori Infection Treatment |
|
|
| Not yet recruiting | 4 | 160 | Europe | Clarithromycin (mutations in the 23S rRNA gene, A2134G, A2142G and A2142C mutations) and levofloxacin resistance (mutations in the gyrA gene) PCR test, Empirically H. pylori eradication treatment with bismuth quadruple therapy (Pylera®), PPI, amoxicillin 1 g and clarithromycin 500 mg, twice daily, for 10 days, PPI, amoxicillin 1g and levofloxacin 250 mg, twice daily, for 10 days, Bismuth quadruple therapy (Pylera®) for 10 days | Manuel Coelho da Rocha | Helicobacter Pylori Infection | 09/26 | 12/26 | | |
NCT05867654: Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis |
|
|
| Not yet recruiting | 4 | 100 | US | Amoxicillin-clavulanate 875mg/125mg q12hrs, Augmentin, oral clindamycin 300mg q6hrs, Cleocin, Levofloxacin 750mg QID, Levaquin | University of Louisville, Osteo Science Foundation | Osteomyelitis of Jaw | 11/25 | 12/25 | | |
ChiCTR2400088791: Effectiveness and Safety Evaluation of Treatment Regimen for Helicobacter pylori Infection Including Levofloxacin: A Prospective, Randomized Controlled Study |
|
|
| Not yet recruiting | 4 | 334 | | Levofloxacin 50mg per dose, twice a day, orally taken half an hour before breakfast and dinner; Amoxicillin capsules 1000mg per dose, three times a day, orally taken half an hour after breakfast, lunch, and dinner. Oral administration for 14 days.; Lansoprazole 30mg per dose, twice a day, orally taken half an hour before breakfast and dinner; Bismuth potassium citrate capsules 240mg per dose, twice a day, orally taken half an hour before breakfast and dinner; Clarithromycin tablets 500mg per dose, twice a day, orally taken half an hour after breakfast and dinner; Amoxicillin capsules 1000mg per dose, twice a day, orally taken half an hour after breakfast and dinner. | The First Affiliated Hospital of Xiamen University; The First Affiliated Hospital of Xiamen University, Bethune Public Welfare Foundation | Helicobector pylori | | | | |
| Recruiting | 4 | 4447 | RoW | Rabeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin, Amoxicillin, Doxycycline, Tetracycline | Shanghai Zhongshan Hospital | Helicobacter Pylori Infection | 06/26 | 06/26 | | |
ChiCTR2300077130: A randomized controlled trial of tegoprazan-amoxicillin dual therapy and individualized therapy based on drug sensitivity for Helicobacter pylori rescue therapy |
|
|
| Not yet recruiting | 4 | 392 | | 14-day dual regimen with Tegoprazan (Tegoprazan 50 mg bid + amoxicillin 1g TID); 14-day bismuth containing quadruple therapy (Esomeprazole 20 mg bid + bismuth potassium citrate 220 mg bid + antibiotic combination based on drug sensitive test (Combination 1. amoxicillin 1 g bid + clarithromycin 500 mg bid; Combination 2. amoxicillin 1 g bid + levofloxacin 500 mg qd or 200 mg bid; Combination 3. tetracycline 500 mg tid or qid + metronidazole 400 mg tid or qid; Combination 4. amoxicillin 1 g bid + metronidazole 400 mg tid or qid; Combination 5. amoxicillin 1 g bid + tetracycline 500 mg tid or qid. )) | The Eighth Affiliated Hospital, Sun Yet-san University; The Eighth Affiliated Hospital, Sun Yet-san University, Shenzhen Futian district health system research project (FTWS2023001) | helicobacter pylori | | | | |
NCT06065267: Levofloxacin Concomitant Versus Levofloxacin Sequential |
|
|
| Not yet recruiting | 4 | 150 | RoW | sequential, Esomeprazole, levofloxacine, metronidazole, amoxicillin, Levofloxacin 500Mg Oral Tablet, Amoxicilline, Esomeprazol, Tinadizole | Damascus Hospital | Helicobacter Pylori Infection | 12/26 | 06/27 | | |
ChiCTR1900028674: Pregnancy Exposure Registry in the first trimester for Levofloxacin and the safety study on the development of offspring followed to adulthood |
|
|
| Recruiting | 4 | 1000 | | NA | Women's Hospital School Of Medicine Zhejiang University; Women's Hospital School Of Medicine Zhejiang University, Self-financing | pregnancy | | | | |
ACTRN12624000654550: Evaluating the effectiveness of a fluoroquinolone-based treatment of isoniazid-resistant tuberculosis: The FLIRT Trial |
|
|
| Not yet recruiting | 3 | 920 | | | The University of Sydney, National Health and Medical Research Council (NHMRC) | isoniazid-resistant tuberculosis, Mycobacterium tuberculosis | | | | |
2011-000366-35: Tackling early deaths and assessing quality of life in patients with myeloma: assessing the effect of preventative antibiotics on healthcare associated infections |
|
|
| Ongoing | 3 | 1000 | Europe | Levofloxacin, Prixoter 250mg film-coated tablets, Prixoter 250mg film-coated tablets | University of Birmingham, University of Warwick, NIHR HTA | Infections during early symptomatic multiple myeloma | | | | |
2010-024644-15: Concomitant therapy with levofloxacyn versus sequential therapy with levofloxacin for eradication of H. pylori infection Terapia concomitante con levofloxacina verso terapia sequenziale con levofloxacina per l\'eradicazione di H.pylori |
|
|
| Ongoing | 3 | 160 | Europe | Capsule, hard | AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA\' DEGLI STUDI DI NAPOLI, BRACCO S.p.A. | Helicobacter pylori infection Infezione da Helicobacter pylori | | | | |
2017-000334-59: The value of post-operative antibiotic therapy after laparoscopic appendectomy for complicated acute appendicitis (other than for generalized peritonitis): a prospective, randomized, placebo-controlled Phase III study. |
|
|
| Not yet recruiting | 3 | 1494 | Europe | CEFTRIAXONE, levofloxacine kabi 5MG/Ml, METRONIDAZOL, Injection, Infusion, ceftriaxone mylan 2g, poudre pour solution injectable, LEVOFLOXACINE KABI 5 MG/ML, METRONIDAZOLBBRAUN | CHU Amiens-Picardie, DGOS | The value of post-operative antibiotic therapy after laparoscopic appendectomy for complicated acute appendicitis (other than for generalized peritonitis): a prospective, randomized, placebo-controlled Phase III study., The value of post-operative antibiotic therapy after laparoscopic appendectomy for complicated acute appendicitis (other than for generalized peritonitis), Diseases [C] - Digestive System Diseases [C06] | | | | |
2017-005111-14: Helicobacter pylorie eradication with Probiotic Lactobacillus casei rhamnosus LCR35 Alone or in Combination with Antibiotic Therapy |
|
|
| Ongoing | 3 | 440 | Europe | Antibiophilus, Amoxicillin, Levoflaxacin, Anaerobex, Durotiv, Powder for oral solution in sachet, Tablet, Antibiophilus, Amoxicillin, Levoflaxacin Sandoz, Anaerobex, Durotiv | Medical University Innsbruck, Gebro Pharma GmbH, Sandoz GmbH, G.L. Pharma | Helicobacter pylori infection, Helicobacter pylori infection leading to histology-proven chronic gastritis, Diseases [C] - Digestive System Diseases [C06] | | | | |
ACTRN12616000215426: The V-QUIN MDR TRIAL: A randomized controlled trial of six months of daily levofloxacin for the prevention of tuberculosis among household contacts of patients with multi-drug resistant tuberculosis
|
|
|
| Completed | 3 | 2006 | | | University of Sydney, National Health and Medical Reserach Council | tuberculosis, tuberculosis, multi-drug resistant | | | | |
NCT04558463: The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19 |
|
|
| Recruiting | 3 | 100 | RoW | Favipiravir, Avigan® (favipiravir), Oseltamivir 75mg, Oseltamivir | Indonesia University | Covid19 | 09/20 | 10/20 | | |
THD-HP, NCT04107194: Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. |
|
|
| Recruiting | 3 | 362 | Europe | Pantoprazole 40mg, Pantorc, Amoxicillin 1000 MG, Zimox, Clarithromycin 500mg, Klacid, Metronidazole, Flagyl, Tetracycline 125 MG, Ambramicina, Bismuth Subcitrate, Denol, Rifabutin 150 MG, Mycobutin, Levofloxacin 500mg, Levoxacin | University of Bari | Helicobacter Pylori Infection, Antibiotic Resistant Infection, Antibiotic Resistant Strain | 02/21 | 04/22 | | |
| Completed | 3 | 162 | RoW | Sequential Regimen: Levofloxacin 500 mg BID, Amoxicillin 1 gm BID, omeprazole 20 mg BID for first five days followed by Levofloxacin 500 mgBID, Tinidazole 500 mg BID, Omeprazole 20 mg BID, Levofloxacin, Amoxicillin, Omeprazole, Tinidazole, Triple Regimen: Moxifloxacin 400mg OD, Amoxicillin 1 gm BID, Omeprazole 20mgBID, Moxifloxacin | Iyad Naeem Muhammad, PhD | Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to | 12/21 | 06/22 | | |
NCT03779074: Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies |
|
|
| Completed | 3 | 918 | RoW | 10d bismuth quadruple therapy, rabeprazole 20 mg bid, tripotassium dicitrate bismuthate 300mg qid, tetracycline 500 mg qid, metronidazole 250 mg qid, 14d hybrid therapy, amoxicillin 1 g bid, clarithromycin 500 mg bid, metronidazole 500 mg bid, 14D high-dose dual therapy, rabeprazole 20 mg qid, amoxicillin 750 mg qid | Kaohsiung Veterans General Hospital. | Helicobacter Pylori Infection | 12/21 | 12/21 | | |
2021-003914-38: Different antimicrobial durations for the treatment of infections associated with OsteosynthesisMaterial implanted after long bone fractures DIFERENTES DURACIONES DE TRATAMIENTO ANTIMICROBIANO DE INFECCIONES ASOCIADAS AL MATERIAL DE OSTEOSÍNTESIS TRAS FRACTURA DE HUESO LARGO |
|
|
| Not yet recruiting | 3 | 378 | Europe | Ampicillim, amoxicillin/clavulanic, Cefazolin, Cefepime, Ceftazidime, CEFTRIAXONE, cloxacillin, daptomycin, Meropenem, Teicoplanin, Vancomycin, Amoxicillin, Amoxicillin / clavulanic acid, Ciprofloxacin, Levofloxacin, Linezolid, Moxifloxacin, Rifampicin, Powder and solvent for solution for infusion, Powder and solvent for solution for injection, Powder for solution for injection, Powder and solvent for suspension for injection, Powder for solution for injection/infusion, Tablet, , Capsule, Ampicillim, Amoxicillin/Clavulanic, Cefazolin, Cefepime, ceftazidime, CEFTRIAXONE, cloxacillin, daptomycin, Meropenem, Teicoplanin, Vancomycin, Amoxicillin, Amoxicillin / clavulanic acid, Ciprofloxacin, Clindamycin, Sulfametoxazol trimetoprim, Levofloxacin, Linezolid, Moxifloxacin, Rifampicin | Fundación Pública Andaluza para la Gestión de la Investigación, Instituto de Salud Carlos III. Ministerio de Ciencia e | Patients with long bone fractures who have had osteosynthesis material implanted to stabilize and assist fracturehealing and meet the criteria for Infections associated with osteosynthesis material Pacientes con fracturas de huesos largos a quienes se les ha implantado material de osteosíntesis para estabilizar y ayudar a la curación de la fractura y que cumplen con los criterios de Infecciones asociadas con el material de osteosíntesis., Patients with infections due to the implant used to stabilize a long bone fracture Pacientes con infecciones debidas al implante usado para estabilizar una fractura de hueso largo, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
ACTRN12618001236280: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors |
|
|
| Active, not recruiting | 3 | 420 | | | Alliance for Clinical Trials in Oncology, Australian and New Zealand Urogenital and Prostate Cancer Trials (ANZUP) | Germ Cell Tumor, Teratoma, Choriocarcinoma, Germinoma, Mixed Germ Cell Tumor, Yolk Sac Tumor, Childhood Teratoma, Malignant Germ Cell Neoplasm, Extragonadal Seminoma, Non-seminomatous Germ Cell Tumor, Seminoma, Cancer | | | | |
STREAM, NCT02409290: The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB |
|
|
| Completed | 3 | 588 | RoW | Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Avelox, Clofazimine, Lamprene, Ethambutol, Myambutol, Pyrazinamide, Zinamide, Isoniazid, Nydrazid, Isotamine, Prothionamide, Peteha, Kanamycin, Kantrex, Levofloxacin, Levaquin, Bedaquiline, SIRTURO | IUATLD, Inc, Medical Research Council, Institute of Tropical Medicine, Belgium, Liverpool School of Tropical Medicine, Rede TB | MDR-TB | 05/22 | 05/23 | | |
| Recruiting | 3 | 100 | RoW | Nitazoxanide, Alenia, nitclean, parazoxanide, Levofloxacin, Tavanic, levoxin, venaxan., Doxycyclin, Vibramycin, Doxymycin, Omeprazole, Omepak, Pepzole, Gasec, Risek. | Tanta University | Dyspepsia | 12/22 | 12/22 | | |
NCT05728424: One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL |
|
|
| Recruiting | 3 | 246 | RoW | Vonoprazan, Amoxicillin, Levofloxacin | Aga Khan University, Searle Pharmaceuticals | Helicobacter Pylori Infection | 04/23 | 05/23 | | |
2021-006991-18: Postoperative anti-infective strategy following pancreaticoduodenectomy in patients with preoperative biliary stent Stratégie anti-infectieuse postopératoire après une duodénopancréatectomie chez les patients ayant un stent biliaire préopératoire |
|
|
| Not yet recruiting | 3 | 326 | Europe | PIPERACILLINE/TAZOBACTAM PANPHARMA 4 g/500 mg, poudre pour solution pour perfusion, METRONIDAZOLE B BRAUN 0,5 %, solution pour perfusion, : LEVOFLOXACINE ARROW 5 mg/ml, solution pour perfusion en poche, Powder for solution for infusion, Solution for infusion, PIPERACILLINE/TAZOBACTAM PANPHARMA 4 g/500 mg, poudre pour solution pour perfusion, METRONIDAZOLE B BRAUN 0,5 %, solution pour perfusion, LEVOFLOXACINE ARROW 5 mg/ml, solution pour perfusion en poche | CHU de Rouen, Chu de Rouen | Patients with preoperative biliary stent treated by pancreaticoduodenectomy Patients avec stent biliaire préopératoire traités par duodénopancréatectomie, Patients with preoperative biliary stent treated by pancreaticoduodenectomy Patients avec stent biliaire préopératoire traités par duodénopancréatectomie, Not possible to specify | | | | |
| Completed | 3 | 754 | RoW | Bedaquiline, Sirturo, Delamanid, Deltyba, OPC-67683, Clofazimine, Lamprene, Levofloxacin, Moxifloxacin, Linezolid, Pyrazinamide, Control arm MDR-TB regimen, consistent with WHO guidelines | Médecins Sans Frontières, France, Partners in Health, Harvard Medical School (HMS and HSDM), Epicentre, Institute of Tropical Medicine, Belgium, Socios En Salud, Peru, Interactive Research and Development | Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses | 06/23 | 06/23 | | |
NCT04062201: Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care |
|
|
| Completed | 3 | 402 | RoW | Bedaquiline Oral Tablet, Sirturo, Linezolid Oral Tablet, Zyvox, Delamanid in Oral Dosage Form, Deltyba, Clofazimine Oral Product, Lamprene, Levofloxacin Oral Tablet, Isoniazid Oral Product, INH, Ethambutol Oral Product, Pyrazinamide Oral Product | Wits Health Consortium (Pty) Ltd, Regents of the University of California, University of Cape Town, Perinatal HIV Research Unit of the University of the Witswatersrand | Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis, Multi Drug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis | 04/24 | 04/24 | | |
| Completed | 3 | 232 | RoW | Vonoprazan, Clarithromycin, Amoxycillin, Esomeprazole, Levofloxacin, Doxycicline, Nitazoxanide | Ain Shams University | Helicobacter Pylori Eradication | 06/23 | 06/23 | | |
NCT06414707: Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori |
|
|
| Completed | 3 | 320 | RoW | Vonoprazan, Amoxicillin and Levofloxacin, Vonaspire 20 mg, Amoxil 1 gm, Tavanic 500 mg, Pantoprazole 40mg, Amoxicillin and Levofloxacin, controloc 40 mg | Ain Shams University | Helicobacter Pylori Infection | 04/24 | 04/24 | | |
NCT06684626: The Role of Butirprost® in Combination With Antibiotics in Chronic Bacterial Prostatitis (CBP) Treatment |
|
|
| Completed | 3 | 60 | Europe | Sodium Hyaluronate, Butirprost®, Levofloxacin 500mg | Federico II University | Prostate Inflammation, Prostate Disease, Chronic Bacterial Prostatitis | 07/24 | 09/24 | | |
NCT02701608: Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus |
|
|
| Recruiting | 3 | 324 | Europe | Levofloxacin, Fluoroquinolones, Rifampicin, Conventional IV treatment of staphylococci IE following European guidelines 2015 including cloxacilline, oxacilline,gentamicine,vancomycine,rifampicine | University Hospital, Tours | Infective Endocarditis | 05/24 | 09/24 | | |
| Recruiting | 3 | 732 | RoW | Rifampin, rifampicin, Rifadin, Rimactane, Levofloxacin, Rifampicin, Pyrazinamide, Ethambutol and Isoniazid, Rifafour, Prednisone, Trolic, Placebo | University of Cape Town | Disseminated Tuberculosis, HIV | 06/24 | 12/24 | | |
NCT06526039: A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB |
|
|
| Not yet recruiting | 3 | 100 | NA | a novel short regimen | Taipei Medical University WanFang Hospital, Hualien Tzu Chi General Hospital, Chest Hospital, Ministry of Health and Welfare, Taiwan, Chang-Hua Hospital, Taichung Veterans General Hospital, Taichung Hospital, Ministry of Health and Welfare, Taoyuan General Hospital, Kaohsiung Veterans General Hospital., Kaohsiung Medical University Chung-Ho Memorial Hospital | Tuberculosis, Pulmonary | 12/28 | 12/29 | | |
CHRONOS-2, NCT05074147: Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis |
|
|
| Not yet recruiting | 3 | 280 | Europe | Reduction in the duration of antibiotic therapy 3 weeks or 6 weeks | Tourcoing Hospital | Osteomyelitis - Foot | 11/24 | 11/26 | | |
INSPIRE-BDLL, NCT06649721: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese Cohort |
|
|
| Not yet recruiting | 3 | 120 | RoW | bedaquiline, BDQ, B, delamanid, DLM, D, linezolid, LZD, L, Levofloxacin, LFX, Clofazimine, CFZ, C | Huashan Hospital, Beijing Chest Hospital | Drug-resistant Tuberculosis, Pulmonary Tuberculosis, Rifampin-resistant Tuberculosis | 06/27 | 06/27 | | |
KHDT-SGT, NCT06760065: Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment |
|
|
| Not yet recruiting | 3 | 316 | NA | Keverprazan Hydrochloride tablets + high dose amoxicillin, Susceptibility-Guided Quadruple Therapy | Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou First People's Hospital, The Seventh Affiliated Hospital of Sun Yat-sen University, Longgang District People's Hospital of Shenzhen, Eighth Affiliated Hospital, Sun Yat-sen University, Bao'an District People's Hospital of Shenzhen, Foshan Fuxing Chancheng Central Hospital | Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education | 12/27 | 12/27 | | |
ChiCTR2400084059: A Clinical Study of Life Enhancer Probiotic Capsules Supplementation for the Intervention of Urinary Tract Infections in Middle-aged and Elderly Women |
|
|
| Recruiting | 3 | 30 | | Take Life Enhancer probiotics capsules orally,Twice a day, two at a time; Placebo and Levofloxacin | Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, China.; Shanghai Fourth People’s Hospital, Shanghai Fourth People's Hospital | Urinary Tract Infections | | | | |
| Not yet recruiting | 3 | 2530 | RoW | Bedaquiline, Sirturo, Isoniazid, rifapentine, 3HP, 1HP, Levofloxacin, Levaquin | Johns Hopkins University, Elizabeth Glaser Pediatric AIDS Foundation, United States Agency for International Development (USAID) | Tuberculosis, Latent | 11/29 | 11/30 | | |
| Recruiting | 3 | 20000 | Europe, Canada, Japan, US, RoW | Ceftriaxone, Moxifloxacin or Levofloxacin, Piperacillin-tazobactam, Ceftaroline, Amoxicillin-clavulanate, Standard course macrolide, Extended course macrolide, No systemic corticosteroid, Fixed-duration Hydrocortisone, Shock-dependent hydrocortisone, Fixed-duration higher dose Hydrocortisone, No antiviral agent for influenza, Five-days oseltamivir, Ten-days oseltamivir, No antiviral agent for COVID-19, Lopinavir / Ritonavir, Hydroxychloroquine, Hydroxychloroquine + lopinavir/ritonavir, Ivermectin, No immune modulation for COVID-19, Interferon beta-1a, IFN-β1a, Anakinra, Tocilizumab, Sarilumab, Local standard venous thromboprophylaxis, Therapeutic dose anticoagulation, Conventional low dose thromboprophylaxis, Intermediate dose thromboprophylaxis, Continuation of therapeutic dose anticoagulation, No immunoglobulin, Convalescent plasma, Delayed administration of convalescent plasma, No vitamin C, Vitamin C, No antiplatelet, Aspirin, acetylsalicylic acid, P2Y12 inhibitor, Clopidogrel, Prasugrel, Ticagrelor, No simvastatin, Simvastatin, Eritoran, Apremilast, Clinician-preferred mechanical ventilation strategy, Protocolised mechanical ventilation strategy, No renin-angiotensin system inhibitor, Angiotensin converting enzyme inhibitor, Ramipril, Lisinopril, Perindopril, Enalapril, Trandolapril, Captopril, Angiotensin Receptor Blockers, Losartan, Valsartan, Candesartan, Irbesartan, Telmisartan, Olmesartan, ARB + DMX-200, No cysteamine, Cysteamine, Fixed-duration dexamethasone, Baloxavir Marboxil, Five-days oseltamivir + baloxavir marboxil, Ten-days oseltamivir + baloxavir marboxil, No endothelial modulator, Imatinib, No Immune Modulator for Influenza, Baricitinib, Nirmatrelvir/ritonavir, Paxlovid, Remdesivir, Nirmatrelvir/ritonavir + remdesivir | UMC Utrecht, Australian and New Zealand Intensive Care Research Centre, Medical Research Institute of New Zealand, Unity Health, Berry Consultants, Global Coalition for Adaptive Research, University of Pittsburgh Medical Center, Intensive Care National Audit & Research Centre, St. Marianna University School of Medicine, Nat Intensive Care Surveillance - MORU, National University Hospital, Singapore | Community-acquired Pneumonia, Influenza, COVID-19 | 02/26 | 02/28 | | |
INSPIRE-CODA, NCT06081361: Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort |
|
|
| Recruiting | 3 | 186 | RoW | Bedaquiline, BDQ, Delamanid, DLM, Contezolid, CZD, Levofloxacin, LFX, Moxifloxacin, MFX, Clofazimine, CFZ, Linezolid, LZD, Cycloserine, CS, Prothionamide, Pto, Pyrazinamide, PZA, Para-Aminosalicylic Acid, PAS, Ethambutol, EMB | Beijing Chest Hospital, National Medical Center for Infectious Diseases | Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis | 10/26 | 12/26 | | |
ChiCTR2400084328: A Study of Life Enhancer Probiotic Capsules for the Intervention of Recurrent Urinary Tract Infections in Middle-aged and Elderly Women |
|
|
| Not yet recruiting | 3 | 30 | | Take Life Enhancer probiotics capsules orally,Twice a day, two at a time; Placebo and Levofloxacin | Shanghai Fourth People's Hospital, Affiliated to Tongji University; Shanghai Fourth People's Hospital, Affiliated to Tongji University, Shanghai Fourth People's Hospital | Urinary tract infections | | | | |
NCT06498414: An Adaptive Trial to Find the Safest and Shortest TB Preventive Regimens. |
|
|
| Not yet recruiting | 2/3 | 1800 | Canada, RoW | rifampin standard arm, 4R10, rifampin double dose, 2R20, levofloxacin and rifapentine, 1LP | McGill University Health Centre/Research Institute of the McGill University Health Centre, Canadian Institutes of Health Research (CIHR) | Tuberculosis Infection, Latent | 04/27 | 06/29 | | |
T-CORE2201, jRCTs021230005: A randomized phase 2 study assessing the efficacy and safety of levofloxacin added to the GEM/nabPTX combination therapy in patients with advanced pancreatic cancer |
|
|
| Recruiting | 2 | 140 | Japan | levofloxacin - Generic mfg., gemcitabine - Generic mfg., albumin-bound paclitaxel - Generic mfg. | JR SENDAI HOSPITAL, Tohoku Clinical Oncology Research and Education Society(T-CORE) | Pancreatic Cancer | | | | |
2004-002988-24: A prospective, multicenter, randomized, double-blind, pilot study to evaluate the safety, the efficacy, the tolerability, and the emergence of resistant gram-negative microorganisms in the bowel in elderly patients with serious community-acquired bacterial pneumonia treated with a short regimen fo ertapenem versus high-dose levofloxacin. |
|
|
| Ongoing | 2 | 70 | Europe | INVANZ, TAVANIC, L-000749345, MK-0826, INVANZ TM, TAVANIC(R), INVANZ TM, TAVANIC(R) | Merck Sharp and Dohme de España | Community Acquired Bacterial Pneumonia with criteria of seriousness and great likelihood of polymicrobial or gram-negative microbial etiology. | | | | |
| Completed | 2 | 252 | Europe, RoW | RD03/2016 eye drops, Levofloxacin + Ketorolac Trometamol 0.5+0.5% w/v eye drops solution, Levofloxacin 0.5% eye drops solution (Oftaquix®), Oftaquix® 5 mg/ml eye drops solution | NTC srl, NTC s.r.l, NTC SRL, NTC s.r.l. | Conjunctivitis, Bacterial | 06/23 | 09/23 | | |